Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPACE2: Esomeprazole for Prevention of NSAID-Associated Upper GI Symptoms
NCT00241553Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2001
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of esomeprazole, sponsored by AstraZeneca. Started Apr 2001; status: completed.
02
Drugs
esomeprazole
Beyond the preview
Go deeper on NCT00241553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241553.